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A B S T R A C T
This research was done to evaluate the induction of apoptosis in MDA-MB-231 breast cancer cell line by
Peganum harmala’s extract, in which a signiﬁcant amount of ß-carbolines is included. The apoptosis
incidence was assessed through Annexin-V-Flous kit. The expressions of genes through which intrinsic
apoptosis pathway are involved, Bax, Bcl-2, Bid, and Puma, over the genes the expressions of which are
linked to extrinsic apoptosis pathway, TRAIL, Caspase8, p21, and p53, were examined by RT-PCR and Real-
time PCR. The results demonstrate that the extract decreases the growth rate of the cancer cell line
through inducing apoptosis mechanism. As long as the expression of anti-apoptosis Bcl-2 gen reduced
dramatically, an over-expression in Bax and Puma genes was monitored indicating activation of intrinsic
apoptosis pathway. A notable over-expression observed with TRAIL and Caspase8 genes as well as Bid
gene. The latter is an intermediate for both intrinsic and extrinsic pathways of apoptosis.
ã 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Apoptosis is a programmed cell death which is important in
controlling cell number and proliferation. Apoptosis induces by
two major pathways; extrinsic and intrinsic pathways [8]. Extrinsic
pathway instigates by death signals that ligate to the death
receptor such as TRAIL (tumor necrosis factor-related apoptosis-
inducing ligand) or Fas (TNF Receptor Superfamily) genes. The
death receptors are the member of the tumor necrosis factor (TNF)
receptor gene superfamily containing death domain which is
important in transmitting the death signal from the cell’s surface to
intracellular signaling pathways. The ligation of death receptor and
death signal caused receptor trimerization, recruiting adaptor
molecules such as FADD (Fas-Associated protein with Death
Domain) which results in the activation of the initiator Caspase-
8 and lead to activate downstream effector caspases (cysteine-
aspartic proteases or cysteine-dependent aspartate-directed pro-
teases) such as caspase-3 and ﬁnally DNA fragmentation [9,3].
The other pathway, intrinsic or mitochondrial pathway is
triggered by the release of apoptosis factors such as cytochrome c.
The Bcl-2 (B-cell lymphoma 2) family proteins are crucial for* Corresponding author at: National Institute of Genetic Engineering and
Biotechnology, Tehran freeway 15 km, P.O.BOX 14925/16, Pajouhesh BLV
1417863171, Tehran, Iran. Fax: +98 2144787399.
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2215-017X/ã 2015 The Authors. Published by Elsevier B.V. This is an open access article unintrinsic pathway that inhibit or initiate apoptosis. Antiapoptotic
Bcl-2 family members such as Bcl-2 and Mcl-1 inhibit apoptosis;
however the domain of proapoptotic members such as Bax (Bcl-2-
associated X protein) and Bak (Bcl-2 homologous antagonist/killer)
promote apoptosis and also suppress oncogenesis. Bid (BH3
interacting-domain death agonist), a Bcl-2 family protein with a
BH3 domain only, is a linkage between intrinsic pathway and
extrinsic pathway [9,8].
Evading apoptosis is one of the hallmark of cancer cells [13,14].
The researchers postulated that inducing apoptosis in cancer cells
which is causing no damage to normal cells can be a practical drug
for treating cancer. Therefore, ongoing cancer therapies are looking
for the anti-cancers triggering apoptosis in cancer cells [10,3,9].
Peganum harmala L. (Nitrariaceae) is a local remedy distributed
in the central Asia, Middle East and North Africa. This plant has
been used as folk medicine mostly because of its antibacterial
effect for long time. Studies show the inhibitory effects of P.
harmala on bacteria, parasites, viruses, and cancer cells [2]. Several
reports demonstrated that ß-carboline alkaloids, one of the
phytochemical compound of P. harmala, intercalate to DNA leads
to DNA topoisomerases inhibition [1]. That study addressed that
harmaline and harmalol induce melanogenesis through p38 MAPK
signaling [17]. The researchers suggested the anti-cancer effect of P.
harmala happens mainly as a consequence of inducing apoptosis
[4,11]. Indeed, the impact of harmine on B16f-10 melanoma
revealed that it activates both intrinsic and extrinsic pathways by
up-regulating Bax, Bid, p53 and Caspase-8 genes and down-
regulating Bcl-2 [11]. By contrast, harmine and its derivatives haveder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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P. harmala. The over-expression of Fas and down-regulation of Bcl-2
in cancer cells treated with harmine/its derivatives was observed,
too [6]. Cao et al. [4], have reported that expression of Bcl-2, Mcl-1
(induced myeloid leukemia cell differentiation protein Mcl-1) and
Bcl-xl (B-cell lymphoma-extra large) genes were reduced in HepG
cancer cells while the expression of Bax didn’t change suggesting
that it induces intrinsic pathway in apoptosis [4]. Chen et al. [7]
used 9 harmine derivatives (including harmine) to investigate their
antitumor effects and acute toxicities in mice through the analyses
of IC50 and the expression of Bcl-2 gene. However, they stated that
further studies on the effects of harmine derivatives on key
regulators for tumor cell apoptosis were needed. Hamsa and
Kuttan [12] have demonstrated the anti-angiogenic activity of
harmine using in vivo and in vitro assay systems and concluded
strong angiogenic inhibitory of harmine with the ability to
decrease the proliferation of vascular endothelial cells and
reduction in the expression of various pro-angiogenic factors.
Zhao and Wink [21] have studied harmine activity on telomerase
by analyzing the telomeric repeat ampliﬁcation protocol (TRAP)
and demonstrated signiﬁcant inhibition of telomerase activity and
an induction of an accelerated senescence phenotype by over-
expressing elements of the p53/p21 pathway as a result of harmine
treatment which exhibits a pronounced cytotoxicity on cancer
cells. Sun et al. [19] and Zhang et al. [20] have studied the effects of
paclitaxel and/or harmine on the cell migration and invasion in two
human gastric cancer cell lines and it was elucidated that those
compounds provide a synergistic effect on growth inhibition of
cancer cells via the downregulation of Cyclooxygenase-2 (COX-2)
expression.
Despite all the aforementioned evidences, the underlying
mechanism of harmine effect on cancer cell line most of which
is not clear yet has not been thoroughly supported.
In the previous study, the anti-cancer impact of P. harmala on
cancer cell lines was conﬁrmed by MTT test [18]. In the present
study, the apoptosis assay was used to elucidate the anticancer
effect of P. harmala’s seed extract. The expression of Bax, Bcl-2, Bid
and Puma (p53 upregulated modulator of apoptosis) genes being
involved in intrinsic pathway has been studied as some related
mechanisms of P. harmala’s extract. Furthermore, the gene
expression of TRAIL and Caspase-8 as candidates genes involved
in extrinsic apoptosis pathway was monitored. For further
conﬁrmation, p53 and p21 were traced using quantitative
procedures, real-time PCR.Table 1
List of primer pairs used correlated with apoptosis pathway in human cells.
Accession no.a Target Gene Sequence
(50 ! 30)
NM_001199954.1 b-actin F 
R 
NM_138764.4 Bax F 
R 
NM_000633.2 BCL-2 F 
R 
NM_001244572.1 Bid F 
R 
NM_014417.4 Puma F 
R 
NM_001080125 Caspase-8 F 
R 
NM_001190942.1 TRAIL F 
R 
NM_001126118.1 P53 F 
R 
NM_001220778 p21 F 
R 2. Materials and methods
2.1. Cell culture and preparation
The breast cancer cell line MDA-MB-231, was obtained from
National Institute of Genetic Engineering and Biotechnology,
NIGEB. The cells were cultured in DMEM medium supplemented
with 10% heat-inactivated FBS, penicillin (100 m mL1), and
streptomycin (100 m mL1) at 37 C in a humidiﬁed atmosphere
containing 5% CO2 maintained.
2.2. Chemicals
P. harmala seeds were collected from the mountains of
Shahrekord, Chaharmahalo Bakhtiari province, Iran. The P.
harmala’s alkaloid extract has been prepared according to Seyed
Hasan Tehrani et al. [18].
Annexin-v-ﬂuos staining Kit (Roche Applied Science, France),
RNA extract kit (Roche Applied Science, France), RNeasy Mini Kit
Qiagen (Cat. No. 74104), Master Mix PCR (I intron), QuantiFast SYBR
Green (Qiagen, Cat. No. 204054), Harmine (286044-1G, Sigma,
USA), Harmaline (51330-1G, Sigma, USA) and DMEM, Trypsin, and
FBS (bio idea, Italy) were used for our experiments.
2.3. Apoptosis assay
Annexin-v-ﬂuos staining Kit used for differentiating apoptotic
cells from necrotic cells in the early stage of apoptosis by binding to
the cells including phosphatidyl serine. Cancer cell line MDA-MB-
231 were seeded (1000 cells/well) in 24 well plate and incubated
for 24 h at 37 C in 5% CO2 atmosphere. The concentration of 30 and
100 mg.ml1 of P. harmala’s seed extract was added and incubated
for further 24 and 48 h. After incubation the medium depleted, for
staining with annexin-V, each well was incubated for 15 min at
25 C in 100 ml of a solution containing 20 ml of Annexin-V and
20 ml propidium iodide (30 mg ml1) in 1 ml Hepes buffer (10 mM
Hepes/NaOH pH 7.4; 140 mM NaCl; 5 mM CaCl2). Cells were
washed twice with phosphate-buffered saline and analyzed under
a ﬂuorescence microscopy using an excitation wavelength of
480 nm and detection in the range of 515–565 nm.
2.4. RNA extraction and cDNA synthesis
Total RNA was extracted from MDA-MB-231 cells treated with
30 mg.ml1 concentration of alkaloid extract for 24 h (as theLength sequenceb
AAGGACTCCTATAGTGGGTGACGA 107
ATCTTCTCCATGTCGTCCCAGTTG
TGCCTCAGGATGCGTCCACCAA 175
CCCCAGTTGAAGTTGCCGTCAG
CGGAGGCTGGGATGCCTTTGT 111
CAAGCTCCCACCAGGGCCAAA
CTTGCTCCGTGATGTCTTTC 100
TCCGTTCAGTCCATCCCATTT
GACGACCTCAACGCACAGTA 101
AGGAGTCCCATGATGAGATTG
ATTAGGGACAGGAATGGAACAC 180
GGAGAGGATACAGCAGATGAAG
CCGTCAGCTCGTTAGAAAGACTCCA 103
GCAAGTTGCTCAGGAATGAATGCCC
GAGGTTGGCTCTGACTGTACC 133
TCCGTCCCAGTAGATTACCAC
GGAGACTCTCAGGGTCGAAAAC 90
GGGCTTCCTCTTGGAGAAGATC
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at 24 h (IC50) obtained by MTT test, this combination of time/
concentration has been chosen for the rest of analysis) using the
RNA extraction Kit (RNeasy Mini Kit Qiagen (Cat. No. 74104))
according to the manufacturer’s protocol. The quality of the RNA
samples and concentration were precisely determined using
NanoDrop spectrophotometer. RNA reverse transcription was
performed in a ﬁnal volume of 20 ml using PrimeScriptTM 1st
strand cDNA Synthesis Kit (Takara, Cat. No. 6110, Iran).
2.5. Primer design
Upon a survey on NCBI GenBank, the related sequences for Bax,
Bcl-2, Bid and Puma, TRAIL and Caspase-8 involved in apoptosis
pathway and also p53 gene were selected and the appropriate
primer pairs were designed with lengths ranging from 70 to 186 bpFig. 1. Annexin-v-ﬂuos staining of MDA-MB-231 cells treated with 30 mg ml1 of P. harm
light), (B) untrated cells as control, and (C) cells after 48 h of exposure. The right mirrowith the programs Oligo 6.0. BLASTN searches conducted against
nr (the nonredundant set of GenBank, EMBL, and DDBJ database
sequences) to conﬁrm the total gene speciﬁcity of the nucleotide
sequences chosen for the primers. To avoid ampliﬁcation of
contaminating genomic DNA, one of the two primers or the probe
was placed at the junction between two exons or in a different
exon. Designed primers were purchased from Gene fanavaran
(Iran). The primers details are reported in Table 1.
2.6. RT-PCR
Reverse transcriptase reactions contained 20 ng of RNA
samples, 50 nM RT random hexanucleotide primers (Amersham
Pharmacia Biotech, Piscataway, NJ), 1 RT buffer (10 mM Tris–HCl,
0.1 M KCl, 0.05% [wt/vol] Tween 20, 0.75 mM EGTA [pH 8.3], 2 mM
deoxyribonucleoside triphosphates, 2.5 mM MgCl2, 3.3 U.ml1ala L.’s seed extract. (A) after 24 h of exposure (cells emitted green under excitation
rs of each micrograph is negative of its related one.
Fig. 2. Impact of P. harmala L.’s seed extract on the expression of different genes.
MDA-MB-231 cells were treated with 30 mg ml1 of the extract for 24 h. Expression
of beta-actin was used to normalize the conditions.
PUMA: p53 upregulated modulator of apoptosis, Bax: Bcl-2-associated X protein,
Bid: BH3 interacting-domain death agonist, Bcl-2: B-cell lymphoma 2, TRAIL: tumor
necrosis factor-related apoptosis-inducing ligand, caspases: cysteine-aspartic
proteases or cysteine-dependent aspartate-directed proteases, p53: phosphopro-
tein p53 or tumor suppressor p53, p21: cyclin-dependent kinase inhibitor 1 or CDK-
interacting protein 1.
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cDNA Archive kit of Applied Biosystems). The reaction mixture was
sequentially incubated in an Applied Biosystems 9800 Thermo-
Cycler for 30 min at 16 C, 30 min at 42 C, 5 min at 85 C. The
reverse transcription reaction was stopped by heating to 95 C for
5 min. Next, 0.5 U of RNase H (Invitrogen) was added, and the
reaction mixture was incubated at 37 C for an additional 30 min.
Ampliﬁed PCR (15 ml) products were electrophoresed on a
standard 1.8% agarose gel having stained with ethidium bromide
and photograph under UV light.
2.7. Real-time quantitative PCR (qPCR)
The synthesized cDNA was quantiﬁed by the QuantiFast SYBR
Green (Qiagen, Cat. No. 204054) according to the manufacturer’s
protocol. For each PCR run, 1 ml primer (10 mM) and 300 ng.ml1
cDNA were added to the PCR master mix and reached to the ﬁnal
volume of 20 ml. Real-time PCR was performed with an ABI Prism
5700 or ABI Prism 7700 machine (Applied Biosystems, USA) and
universal cycling conditions (2 min at 50 C, 10 min at 95 C,
40 cycles of 15 s at 95 C, and 1 min at 60 C). Experiments were
performed with duplicates for each data point. No template was
added to negative control reactions. In order to quantify speciﬁc
gene expression, the mRNA level in each sample was calculated
relative to beta-actin. The Ct data was determinate using default
threshold settings. The threshold cycle (Ct) is deﬁned as the
fractional cycle number at which the ﬂuorescence passes the ﬁxed
threshold. The relative quantiﬁcation of gene expression was
analyzed by the DDCt method. The expected size of PCR products
and not having primer dimer were conﬁrmed by gel electrophore-
sis on a standard 1.2% agarose gel stained with ethidium bromide
and visualized under UV light.
2.8. Statistical analysis
The reaction efﬁciencies were estimated using the LinReg tool
for each sample, the expression ratios were tested by random
pairwise reallocation using REST software.
3. Results
3.1. Apoptosis analysis
Apoptosis, a normal phenomenon, through which a suicide
program is activated within the cell occurs frequently in
multicellular organisms, however is associated with DNA frag-
mentation, cytoplasm shrinkage, membrane changes and ﬁnally
cell death without releasing harmful substances into the
surrounding area.
Upon treating MDA-MB-231 cancer cell line with P. harmala L.’s
seed extract several changes were observed depending the
concentration and time of exposure of which 30 mg ml1
concentration of the extract lead to a signiﬁcant growth rate
reduction and the minimum lethal dose that kills approximately
50% of cells at 24 h (IC50). Providing more deleterious sign for the
later concentration was responsible for smaller cell size and more
shrunk cytoplasm (data are not shown).
3.2. Annexin-v-ﬂuos assay
To validate apoptosis pathway induction and cell death
occurrence as its consequence, Annexin-v-ﬂuos assay was used.
Cancer cell line MDA-MB-231 were treated with 30 mg.ml1
concentration of P. harmala L.’s seed extract and were observed
under ﬂuorescence light after 24 and 48 h. The 100% percentage oftreated cells was ﬂuorescent green while untreated cells didn’t
emit any green light (Fig. 1).
3.3. Gene expression analysis
The quantitative and qualitative analyses of gene expression by
which a reliable calculation of the gene functions in a cell get
evidenced need to be traced. Thus, the expressions of the genes
involved in intrinsic apoptosis pathway namely, Bax, Bcl-2, Bid, and
Puma as well as the genes involved in extrinsic apoptosis pathway
such as TRAIL and Caspase-8 and two more genes, p21 and p53,
were evaluated qualitatively and quantitatively by RT-PCR and
Real-time PCR, respectively.
In order to investigate mRNA differential expression in MDA-
MB-231 cancer cell line, the impact of P. harmala L.’s seed extract
([30 mg ml1]/24 h) were conducted as well.
Fig. 5. Apoptosis and growth related gene expression in cells treated by P. harmala
L.’s seed extract. The p53, p21 genes expression were signiﬁcantly elevated.
p53: phosphoprotein p53 or tumor suppressor p53, p21: cyclin-dependent kinase
inhibitor 1 or CDK-interacting protein 1.
Fig. 3. Intrinsic apoptosis-related gene expression in cells treated by P. harmala L.’s
seed extract. Pro-apoptotic genes, Bax,Puma, and Bid, were up-regulated while the
anti-apoptotic gene, Bcl-2 showed less expression compare to control.
Bcl-2: B-cell lymphoma 2, Bid: BH3 interacting-domain death agonist, PUMA:
p53 upregulated modulator of apoptosis, Bax:(Bcl-2-associated X protein.
142 S. Hashemi Sheikh Shabani et al. / Biotechnology Reports 8 (2015) 138–143Fig. 2 shows changes in the expression of eight genes involving
apoptosis pathway compared to a housekeeping gene (beta-actin)
in MDA-MB-231cell line under two conditions, being treated with
P. harmala L.’s seed extract and keeping the cells untreated. RT-PCR
result showed that the expression of pro-apoptotic genes Puma,
Bax, and Bid involving in intrinsic pathway increased signiﬁcantly
in comparison with control, while the anti-apoptotic gene Bcl-2
diminished. Meanwhile the extrinsic gene TRAIL and
Caspase8 were up-regulated, also the expression of the interme-
diate gene in both intrinsic and extrinsic pathways, Bid, increased
meaningfully. The ﬁgure also reveals the overexpression in p53 and
p21 genes compared to their control (Fig. 2).
Accordingly, in real-time PCR analysis, the expression of pro-
apoptotic genes, Bax, Puma, and Bid, increased 4.926, 4.045,
1.57 times, respectively, despite the expression of Bcl-2 decreased
(1.307 times) when compared with its respected control (Fig. 3).
Further studies on the extrinsic gene expression demonstrated that
the death receptor genes, TRAIL and Caspase-8 were up-regulated
rising to 1.571 and 1.867 times, respectively (Figs. 4 and 5).
However, the highest over-expression is dedicated to p53 gene
(3.938). Additionally, the expression of p21 gene rose to 1.64 time
in the treated cells (Fig. 4).
4. Discussion
The anti-cancer effect of P. harmala’s seed extract on decreasing
the growth rate of cancer cells has been approved according to our
previous study. In the present study, we scrutinized this impact at
molecular level through following up the expression of some
related genes. The morphological changes including damaged cell
membrane and cell shrinkage are the features of apoptosis asFig. 4. Extrinsic apoptosis-related gene expression in cells treated by P. harmala L.’s
seed extract. TRAIL and Caspase-8 genes expression increased.suggested by [16] on cancer cell death caused by apoptosis
pathway. This was conﬁrmed by Annexin-v-ﬂuos assay as well. The
treated cells all of which were green under ﬂuorescence light (and
obviously not red) were damaged into their nucleolus. This means
that apoptosis triggers death in cancer cells and leaves out the
necrosis as an option. This phenomena would be intensiﬁed by
increasing the exposure time (from 24 h to 48 h) and the most
deleterious cell death was observed at 48 h as shown in Fig. 1 (the
mirrors of 1A and 1C micrographs).
It is noteworthy that apoptosis is mainly induced by two
pathways; extrinsic and intrinsic. Admittedly, in this study we
examined the effect of P. harmala L.’s seed extract through which
apoptosis pathway are induced. As a result of the fact that extrinsic
pathway gets triggered by ligation of death signal and receptors,
Caspase-8 gene is activated as a consequence of intracellular
signaling. The active Caspase-8 initiate Caspase cascade the role of
which on morphology of apoptosis is not clear [8].
The expression of two genes TRAIL, death receptor, and Caspase-
8, associated with extrinsic pathway, which were followed by RT-
PCR and Real-time PCR demonstrated up-regulation of both genes
upon treating with P. harmala L.’s seed extract suggesting that the
extract induces mainly on apoptosis extrinsic pathway.
On the other hand, to identify the cooperation of intrinsic
pathways in anti-cancer effect of P. harmala L.’s seed extract, Bcl-2
gene family was mainly followed up. The pro-apoptotic genes, BH3
multidomain, Bax (Bcl-2-associated X protein) and Bak (Bcl-2
homologous antagonist/killer) caused permeability in mitochon-
drial membrane which was inhibited by anti-apoptotic proteins,
Bcl-2, Bcl-xl. As a consequence of binding BH3-only proteins (BID,
BIM (Bcl-2-like protein 11), BAD (Bcl-2-associated death promoter),
and PUMA to anti-apoptotic proteins, their activities were
inhibited. However, in this research Bcl-2 as an anti-apoptotic
protein, Bax as a BH3 multidomain pro-apoptotic protein and PUMA
as BH3-only domaim pro-apoptotic protein were selected for
evaluation of related genes affecting the intrinsic pathway. Bid also
studied not only as a pro-apoptotic protein but also as linkage
between intrinsic pathway and extrinsic pathway [8].
Expression analysis of mRNA by RT-PCR and Real-time PCR
revealed that expression of antiapoptotic gene, Bcl-2 decreased in
treated cell in compare to control while the pro-apoptotic genes
such as Bax, Puma, Bid increased. All the results support each other
and propose that the P. harmala’s seed extract induces intrinsic
pathway when exposed to cell lines.
The expression changes of p53 and p21 in MDA-MB-231 cancer
cell line treated with P. harmala’s seed extract were also studied.
Both p53 and p21 were up-regulated in treated cells in compared
with their respected control. Accordingly, it approved that P.
harmal’s seed extract decreases the cell growth rate, hence p53 as
transcription regulator up-regulates Bax, Puma and TRAIL [15,5].
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Cancer cells grow and divide further from normalcy due to
losing the general controls over the growth. Traditional treatments
involve diminishing the growth rate of cancer cells by means of
exposing it against a medicinal herb extract. In the present study, P.
harmala L.’s seed extract exposed on a MDA-MB-231 cancer cell
line and its growth inhibition was followed through both
morphological changes observation and following genes involved
programme cell death.
P. harmala L.’s seed extract induced cell death and decreased the
cell growth in the breast cancer cell line. The cell death was caused
by apoptosis which was triggered by both intrinsic and extrinsic
pathways which suggest that herb might be useful for preventing
the development of tumors.
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